Synergistic effect of atorvastatin and Cyanidin-3-glucoside on angiotensin II-induced inflammation in vascular smooth muscle cells (Q46582900)

23 December 2017

title

Synergistic effect of atorvastatin and Cyanidin-3-glucoside on angiotensin II-induced inflammation in vascular smooth muscle cells (English)

1 reference

23 December 2017

author name string

Rungusa Pantan

1

1 reference

23 December 2017

Jiraporn Tocharus

2

1 reference

23 December 2017

Apichart Suksamrarn

3

1 reference

23 December 2017

Chainarong Tocharus

4

1 reference

23 December 2017

language of work or name

English

0 references

publication date

5 March 2016

1 reference

23 December 2017

Experimental Cell Research

published in

1 reference

23 December 2017

volume

342

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

104-112

1 reference

23 December 2017

Cyanidin-3-O-glucoside modulates intracellular redox status and prevents HIF-1 stabilization in endothelial cells in vitro exposed to chronic hypoxia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Nuclear factor kappaB signaling in atherogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Biological effects of the superoxide radical

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

The pharmacogenomics of statins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

The immune system in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Inducible nitric oxide synthase in human diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

The nuclear factor NF-kappaB pathway in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Pleiotropic effects of statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Inflammation and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Cyanidin-3-glucoside suppresses TNF-α-induced cell proliferation through the repression of Nox activator 1 in mouse vascular smooth muscle cells: involvement of the STAT3 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Nrf2-Keap1 defines a physiologically important stress response mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infraction (MI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Inflammation and atherosclerosis: direct versus indirect mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Molecular mechanisms of angiotensin II-induced vascular injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Cyanidin-3-O-glucoside counters the response to TNF-alpha of endothelial cells by activating Nrf2 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Cyanidin-3-O-glucoside protection against TNF-α-induced endothelial dysfunction: involvement of nuclear factor-κB signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Color and antioxidant properties of cyanidin-based anthocyanin pigments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Reactive oxygen species are involved in regulating alpha1-adrenoceptor-activated vascular smooth muscle contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Synergy research: approaching a new generation of phytopharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Cellular antioxidant effects of atorvastatin in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

Synergistic inhibition of interleukin-6 production in adipose stem cells by tart cherry anthocyanins and atorvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.02.017

10.1016/J.YEXCR.2016.02.017

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017